In this insightful session, Caroline Michie delves into the latest advancements in the management of metastatic breast cancer, offering a comprehensive overview of emerging therapies and treatment strategies. Dr Michie brings her expertise to the forefront, providing practical guidance and the latest evidence-based practices to help clinicians navigate the evolving landscape of metastatic breast cancer management.
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Dr. Michie, faculty for this educational event, has the following disclosures:
- Consulting/Educational: AstraZeneca, Eisai, Eli Lilly, Gilead, Novartis, Pfizer, Roche, Exact Sciences, MSD, Seagen
- Advisory Board: Astra Zeneca, Gilead
- Travel grants: Roche, Novartis, MSD
- Institutional research support: Astra Zeneca